Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
Clinical trial NCT02191397 · COMPLETED
Trial details
- NCT number
- NCT02191397
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-10
- Primary completion
- 2016-10-10
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.